MedTrace Logo

Ionized Magnesium Balance During Hemodialysis Session

NCT05337436 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-04-27

No results posted yet for this study

Summary

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the balance of total and ionized magnesium according to different types of dialysate used in clinical practice (acetate + Mg 0.50 or 0.75 mM vs citrate + Mg 0.50 ou 0.75 mM)

Conditions

  • Chronic Kidney Diseases

Interventions

BIOLOGICAL

Lymphatic drainage

Biological determination in plasma:

BIOLOGICAL

Total and ionized magnesium

Total and ionized magnesium

BIOLOGICAL

Total and ionized calcium

Total and ionized calcium

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Jean-Paul CRISTOL, Prof · CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-07-01
Completion
2022-12-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05337436 on ClinicalTrials.gov